{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lexington",
      "state": "MA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67180",
      "recalling_firm": "Cubist Pharmaceuticals, Inc.",
      "address_1": "65 Hayden Ave",
      "address_2": "N/A",
      "postal_code": "02421-7994",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide and Puerto Rico.",
      "recall_number": "D-0229-2015",
      "product_description": "CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only,  Single use Vial, Manufactured for: Cubist Pharmaceuticals Inc., Lexington, MA 02421, USA, NDC 67919-011-01",
      "product_quantity": "371,879 Vials",
      "reason_for_recall": "Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.",
      "recall_initiation_date": "20140808",
      "center_classification_date": "20141030",
      "termination_date": "20160729",
      "report_date": "20141105",
      "code_info": "Lot #'s: CDC203, Exp 12/2015; CDC207, Exp 01/2016; CDC213, Exp 02/2016; CDC217, Exp 03/2016; CDC226, Exp 04/2016; CDC234, CDC235, Exp 05/2016; CDC243, CDC246, Exp 07/2016.",
      "more_code_info": ""
    }
  ]
}